Proposal of a prediction model for prognosis of patients with acute myocardial infarction after percutaneous coronary intervention based on galectin-3 and soluble growth stimulating expressed gene 2 levels
Background: To study the correlations of serum galectin-3 (Gal-3) and soluble growth stimulating expressed gene 2 (sST2) levels with prognosis of patients with acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI).
Main Authors: | Zhang Fuxia, Yu Fuchao, Song Songsong, Yang Hongfei, Shao Liangfa, Tong Jiayi |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2022-04-01
|
Series: | Romanian Journal of Laboratory Medicine |
Subjects: | |
Online Access: | https://doi.org/10.2478/rrlm-2022-0019 |
Similar Items
-
Trend of Galectin-3 Levels in Patients with Non-ST-Elevation and ST-Elevation Myocardial Infarction
by: Branka Mitić, et al.
Published: (2022-02-01) -
CORRELATION BETWEEN SERUM LEVEL GALECTIN-3 AND EARLY REMODELLING INDICATOR OF LEFT VENTRICLE IN PATIENT WITH ACUTE MYOCARDIAL INFARCTION DURING PRE-PERCUTANEOUS CORONARY INTERVENTION
by: I Nyoman Indrawan Mataram, et al.
Published: (2019-09-01) -
Galectin-3 – prospective biomarker of risk stratification in patients with ST-segment elevation myocardial infarction
by: N. V. Fedorova, et al.
Published: (2015-12-01) -
The relationship between galectin-3 and SYNTAX Score I in patients with non-ST-segment elevation myocardial infarction
by: Alaa Quisi, et al.
Published: (2020-11-01) -
Galectin-3 and its relationship with the state of coronary arteries in patients with acute myocardial infarction and concomitant obesity
by: O. S. Yermak, et al.
Published: (2019-02-01)